The Influenza Diagnostics Market size to grow at a CAGR of 6.95% from 2022 to 2027| Early detection of influenza will drive growth - Technavio

NEW YORK, Aug. 2, 2023 /PRNewswire/ -- The influenza diagnostics market is estimated to grow at a CAGR of 6.95% from 2022 to 2027. The market size is forecast to increase by USD 466.18 million, according to Technavio – Download a Sample Report

Influenza Diagnostics Market Insights -

• Vendors: 15+, Including Abbott Laboratories, Becton Dickinson, and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis Group NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Quidelortho Corp., among others
• Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
• Segments: end-user (hospitals and diagnostic laboratories, academic and research centers, and homecare), type (point-of-care testing, immunodiagnostics, and molecular diagnostics), and geography (North America, Europe, Asia, and Rest of World (ROW))

To understand more about the influenza diagnostics market, request a sample report

Influenza diagnostics market - Vendor Insights

The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market's competitive landscape and offers information on several market vendors including - Abbott Laboratories, Becton Dickinson, and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis Group NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Quidelortho Corp.

Influenza Diagnostics Market – Market Dynamics

Key Driver

The early detection of influenza is a key factor driving market growth. Influenza, a prevalent viral infection, impacts a substantial portion of the global population annually. The increasing number of influenza cases has resulted in a greater demand for diagnostic tests to detect and manage the infection early. Furthermore, during influenza outbreaks, the number of influenza cases increases significantly, increasing the need for diagnostic tests to detect and monitor the spread of the virus. In response to this seasonal demand, diagnostic manufacturers are providing healthcare facilities with influenza diagnostic kits and tests to meet their growing testing needs. Hospitals, clinics, and laboratory systems are experiencing an increased presence of influenza strains, necessitating reliable and efficient diagnostics to manage more significant numbers of patients effectively during the influenza season Hence, early detection of influenza is expected to drive market growth during the forecast period.

Major Trends

The rising adoption of rapid diagnostic products in physician office laboratories is a major trend in the market. Manufacturers in target markets are increasingly focused on providing affordable and rapid testing using immunoassays and molecular diagnostics. These tests are widely used in clinic medical laboratories to provide rapid results and timely diagnoses during patient visits. Contributions to value-based care programs and quality-payment initiatives drive increased laboratory work in clinics, thereby reducing the need for patient hospitalization. This has helped accelerate the introduction of laboratory testing practices, increasing demand for influenza testing products in such laboratories. For example, in the US, there has been a steady increase in the placement of laboratories in clinics due to the benefits of Medicare billing. Hence, these factors are expected to drive market growth during the forecast period.

Significant Challenge

The lack of laboratory infrastructure in developing regions is a significant challenge restricting market growth. Developing countries face challenges in establishing and maintaining well-equipped influenza diagnostic laboratories. Limited access to diagnostic resources makes it difficult to diagnose influenza cases quickly and accurately. This challenge is due to inadequate infrastructure, lack of trained staff, and limited diagnostic tools and reagents available. In addition, remote areas often lack adequate testing facilities, making timely influenza diagnosis impossible, especially in areas without established healthcare systems. As a result, this challenge hinders disease surveillance efforts and the ability to track and respond to influenza outbreaks effectively. Hence, these factors are expected to restrict market growth during the forecast period.

Drivers, & Challenges have an impact on market dynamics and can impact businesses. Find some insights from a sample report!

The influenza diagnostics market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as prospects.

Why Buy?

• Add credibility to strategy.
• Analyzes competitor's offerings. 
• Get a holistic view of the market.
• Grow your profit margin with Technavio- Buy the Report

What are the key data covered in this Influenza Diagnostics Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the influenza diagnostics market between 2023 and 2027
• Precise estimation of the size of the influenza diagnostics market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the influenza diagnostics market across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of influenza diagnostics market vendors.

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports

The companion diagnostics market is estimated to grow at a CAGR of 22.59% between 2022 and 2027. The market size is forecast to increase by USD 11,029.63 million. Furthermore, this report extensively covers market segmentation by end-user (life science, health centers, and others), indication (oncology, neurology, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The rising use of personalized medicine is a key factor driving market growth during the forecast period.

The cancer diagnostics market is estimated to grow at a CAGR of 11.3% between 2022 and 2027. The market size is forecast to increase by USD 12,626.21 million. Furthermore, this report extensively covers market segmentation by end-user (hospitals and clinics, and diagnostic laboratories), type (IVD, imaging, and IDT), and geography (North America, Europe, APAC, and the Rest of the World (ROW)). The high prevalence of cancer is a key factor driving market growth during the forecast period.

Table of Contents

1 Executive Summary

• 1.1 Market Overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global Influenza Diagnostics Market 2023-2027 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on global influenza diagnostics market 2023-2027 2017 - 2021 ($ million)

• 4.2 End-user Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

• 4.3 Type Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)

• 6.2 Comparison by End-user 
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user

• 6.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)

• 6.4 Academic and research centers - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Academic and research centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Academic and research centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Academic and research centers - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Academic and research centers - Year-over-year growth 2022-2027 (%)

• 6.5 Homecare - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Homecare - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Homecare - Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by End-user 
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 48: Chart on Type - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Type - Market share 2022-2027 (%)

• 7.2 Comparison by Type
• Exhibit 50: Chart on Comparison by Type
• Exhibit 51: Data Table on Comparison by Type

• 7.3 Point-of-care testing - Market size and forecast 2022-2027 
• Exhibit 52: Chart on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Point-of-care testing - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Point-of-care testing - Year-over-year growth 2022-2027 (%)

• 7.4 Immunodiagnostics - Market size and forecast 2022-2027 
• Exhibit 56: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)

• 7.5 Molecular diagnostics - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Type 
• Exhibit 64: Market opportunity by Type ($ million)
• Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 67: Chart on Market share by geography 2022-2027 (%)
• Exhibit 68: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 China - Market size and forecast 2022-2027 
• Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027 
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 France - Market size and forecast 2022-2027 
• Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.11 Canada - Market size and forecast 2022-2027 
• Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 107: Market opportunity by geography ($ million)
• Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 114: Matrix on vendor position and classification

• 12.3 Abbott Laboratories
• Exhibit 115: Abbott Laboratories - Overview
• Exhibit 116: Abbott Laboratories - Business segments
• Exhibit 117: Abbott Laboratories - Key news
• Exhibit 118: Abbott Laboratories - Key offerings
• Exhibit 119: Abbott Laboratories - Segment focus

• 12.4 Becton Dickinson and Co. 
• Exhibit 120: Becton Dickinson and Co. - Overview
• Exhibit 121: Becton Dickinson and Co. - Business segments
• Exhibit 122: Becton Dickinson and Co. - Key news
• Exhibit 123: Becton Dickinson and Co. - Key offerings
• Exhibit 124: Becton Dickinson and Co. - Segment focus

• 12.5 BICO Group AB
• Exhibit 125: BICO Group AB - Overview
• Exhibit 126: BICO Group AB - Business segments
• Exhibit 127: BICO Group AB - Key offerings
• Exhibit 128: BICO Group AB - Segment focus

• 12.6 Bio Rad Laboratories Inc. 
• Exhibit 129: Bio Rad Laboratories Inc. - Overview
• Exhibit 130: Bio Rad Laboratories Inc. - Business segments
• Exhibit 131: Bio Rad Laboratories Inc. - Key news
• Exhibit 132: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 133: Bio Rad Laboratories Inc. - Segment focus

• 12.7 Biocartis Group NV
• Exhibit 134: Biocartis Group NV - Overview
• Exhibit 135: Biocartis Group NV - Product / Service
• Exhibit 136: Biocartis Group NV - Key offerings

• 12.8 bioMerieux SA
• Exhibit 137: bioMerieux SA - Overview
• Exhibit 138: bioMerieux SA - Product / Service
• Exhibit 139: bioMerieux SA - Key offerings

• 12.9 Danaher Corp.
• Exhibit 140: Danaher Corp. - Overview
• Exhibit 141: Danaher Corp. - Business segments
• Exhibit 142: Danaher Corp. - Key news
• Exhibit 143: Danaher Corp. - Key offerings
• Exhibit 144: Danaher Corp. - Segment focus

• 12.10 DiaSorin SpA
• Exhibit 145: DiaSorin SpA - Overview
• Exhibit 146: DiaSorin SpA - Business segments
• Exhibit 147: DiaSorin SpA - Key news
• Exhibit 148: DiaSorin SpA - Key offerings
• Exhibit 149: DiaSorin SpA - Segment focus

• 12.11 F. Hoffmann La Roche Ltd. 
• Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus

• 12.12 Hologic Inc.
• Exhibit 155: Hologic Inc. - Overview
• Exhibit 156: Hologic Inc. - Business segments
• Exhibit 157: Hologic Inc. - Key news
• Exhibit 158: Hologic Inc. - Key offerings
• Exhibit 159: Hologic Inc. - Segment focus

• 12.13 Princeton BioMeditech Corp. 
• Exhibit 160: Princeton BioMeditech Corp. - Overview
• Exhibit 161: Princeton BioMeditech Corp. - Product / Service
• Exhibit 162: Princeton BioMeditech Corp. - Key offerings

• 12.14 Quidelortho Corp.
• Exhibit 163: Quidelortho Corp. - Overview
• Exhibit 164: Quidelortho Corp. - Product / Service
• Exhibit 165: Quidelortho Corp. - Key offerings

• 12.15 Sd Biosensor Inc.
• Exhibit 166: Sd Biosensor Inc. - Overview
• Exhibit 167: Sd Biosensor Inc. - Product / Service
• Exhibit 168: Sd Biosensor Inc. - Key offerings

• 12.16 Siemens Healthineers AG 
• Exhibit 169: Siemens Healthineers AG - Overview
• Exhibit 170: Siemens Healthineers AG - Business segments
• Exhibit 171: Siemens Healthineers AG - Key news
• Exhibit 172: Siemens Healthineers AG - Key offerings
• Exhibit 173: Siemens Healthineers AG - Segment focus

• 12.17 Thermo Fisher Scientific Inc. 
• Exhibit 174: Thermo Fisher Scientific Inc. - Overview
• Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 176: Thermo Fisher Scientific Inc. - Key news
• Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 179: Inclusions checklist
• Exhibit 180: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 181: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 182: Research methodology
• Exhibit 183: Validation techniques employed for market sizing
• Exhibit 184: Information sources

• 13.5 List of abbreviations
• Exhibit 185: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED